6547.TWO
Price:
$37.55
Market Cap:
$12.34B
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. The company is developing enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection; influenza vaccine, which has completed Phase III clinical trial to treat influenza; dengue vaccine, which has completed Phase II clinical trial for the treatment of dengue fever; respiratory cell fusion virus (RSV) antibody, which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19- severe special infectious pneumonia...[Read more]
Industry
Biotechnology
IPO Date
2015-09-16
Stock Exchange
TWO
Ticker
6547.TWO
According to Medigen Vaccine Biologics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -75.10. This represents a change of -40.92% compared to the average of -127.11 of the last 4 quarters.
The mean historical PE Ratio of Medigen Vaccine Biologics Corporation over the last ten years is -22.44. The current -75.10 PE Ratio has changed 33.37% with respect to the historical average. Over the past ten years (40 quarters), 6547.TWO's PE Ratio was at its highest in in the September 2024 quarter at 2.46K. The PE Ratio was at its lowest in in the March 2025 quarter at -201.04.
Average
-22.44
Median
-15.29
Minimum
-147.23
Maximum
44.95
Discovering the peaks and valleys of Medigen Vaccine Biologics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 641.42%
Maximum Annual PE Ratio = 44.95
Minimum Annual Increase = -261.21%
Minimum Annual PE Ratio = -147.23
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -147.23 | 641.42% |
| 2023 | -19.86 | 32.63% |
| 2022 | -14.97 | -133.31% |
| 2021 | 44.95 | -261.21% |
| 2020 | -27.88 | 300.14% |
| 2019 | -6.97 | -34.87% |
| 2018 | -10.70 | 5.71% |
| 2017 | -10.12 | -36.77% |
| 2016 | -16.01 | 2.57% |
| 2015 | -15.61 | -8.60% |
The current PE Ratio of Medigen Vaccine Biologics Corporation (6547.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-60.69
5-year avg
-33.00
10-year avg
-22.44
Medigen Vaccine Biologics Corporation’s PE Ratio is less than AP Biosciences Inc (-34.31), less than PharmaEngine, Inc. (6.26), less than Adimmune Corporation (-17.45), less than Acepodia, Inc. (-13.86), less than Tanvex BioPharma, Inc. (-11.30), less than Foresee Pharmaceuticals Co., Ltd. (-9.89), less than Ever Supreme Bio Technology Co., Ltd (27.60), less than TaiDoc Technology Corporation (8.01), less than TaiDoc Technology Corporation (8.01), less than CHO Pharma, Inc. (-26.10),
| Company | PE Ratio | Market cap |
|---|---|---|
| -34.31 | $13.53B | |
| 6.26 | $10.49B | |
| -17.45 | $8.20B | |
| -13.86 | $9.15B | |
| -11.30 | $16.05B | |
| -9.89 | $12.36B | |
| 27.60 | $14.37B | |
| 8.01 | $11.64B | |
| 8.01 | $11.64B | |
| -26.10 | $6.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Vaccine Biologics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medigen Vaccine Biologics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Medigen Vaccine Biologics Corporation's PE Ratio?
How is the PE Ratio calculated for Medigen Vaccine Biologics Corporation (6547.TWO)?
What is the highest PE Ratio for Medigen Vaccine Biologics Corporation (6547.TWO)?
What is the 3-year average PE Ratio for Medigen Vaccine Biologics Corporation (6547.TWO)?
What is the 5-year average PE Ratio for Medigen Vaccine Biologics Corporation (6547.TWO)?
How does the current PE Ratio for Medigen Vaccine Biologics Corporation (6547.TWO) compare to its historical average?